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Development and evaluation of a crosswalk
between the SF-36 physical functioning scale and
Health Assessment Questionnaire disability index
in rheumatoid arthritis
Peter M ten Klooster1*, Martijn AH Oude Voshaar1, Barbara Gandek2, Matthias Rose2,3, Jakob B Bjorner4,5, Erik Taal1,
Cees AW Glas6, Piet LCM van Riel7 and Mart AFJ van de Laar1,8
Abstract
Background: The SF-36 physical functioning scale (PF-10) and the Health Assessment Questionnaire disability index
(HAQ-DI) are the most frequently used instruments for measuring self-reported physical function in rheumatoid arthritis
(RA). The objective of this study was to develop a crosswalk between scores on the PF-10 and HAQ-DI in RA.
Methods: Item response theory (IRT) methods were used to co-calibrate both scales using data from 1791 RA patients.
The appropriateness of a Rasch-based crosswalk was evaluated by comparing it with crosswalks based on a
two-parameter and a multi-dimensional IRT model. The accuracy of the final crosswalk was cross-validated using
baseline (n = 532) and 6-month follow-up (n = 276) data from an independent cohort of early RA patients.
Results: The PF-10 and HAQ-DI adequately fit a unidimensional Rasch model. Both scales measured a wide range of
functioning, although the HAQ-DI tended to better target lower levels of functioning. The Rasch-based crosswalk
performed similarly to crosswalks based on the two-parameter and multidimensional IRT models. Agreement between
predicted and observed scale scores in the cross-validation sample was acceptable for group-level comparisons. The
longitudinal validity in discriminating between disease response states was similar between observed and predicted
scores.
Conclusion: The crosswalk developed in this study allows for converting scores from one scale to the other and can
be used for group-level analyses in patients with RA.
Keywords: Health assessment questionnaire, Item response theory, Linking, Physical functioning, Rheumatoid arthritis,
Short form 36-item health survey (SF-36)
Background
The SF-36 physical functioning scale (PF-10) [1,2] and the
Health Assessment Questionnaire disability index (HAQ-
DI) [3,4] are well-established instruments for measuring
self-reported physical functioning. The SF-36 and the
HAQ-DI were originally developed as generic measures to
allow comparisons across populations [2,5]. but both in-
struments have also been thoroughly examined for use in
several specific conditions, including rheumatoid arthritis
(RA) [6].
Since the inclusion of patient-reported physical disabil-
ity into core sets of outcomes for clinical trials and ob-
servational studies in RA [7,8], an increasing number of
RA studies now assess and report physical functioning.
Although variation in the choice of instrument exists,
the HAQ-DI and PF-10 are among the most frequently
used [9,10]. Both measures, however, differ considerably
in their content, number of items, and scoring proce-
dures, making it difficult to directly compare results ob-
tained with the two scales. One way to overcome this
problem is to link scores from the HAQ-DI and PF-10
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[11]. This would allow the development of a concord-
ance table, or crosswalk, to convert scores from one in-
strument to another and enable comparison of data
from studies that used either one of the instruments.
Several methods are available for linking scale scores
that vary in design, statistical techniques, and the degree
to which exchangeability can be achieved [11,12]. Item re-
sponse theory (IRT) offers a flexible and powerful frame-
work for score linking by its inherent ability to calibrate
different items of the same concept on a common under-
lying metric [13-16]. Several examples of how to use IRT
modeling to develop crosswalks between different instru-
ments intended to measure the same health domain have
been reported [17-20]. IRT, however, makes certain as-
sumptions about the nature of the data, in particular with
respect to dimensionality. A variety of models are avail-
able, which differ in their restrictiveness with respect to
the assumptions made and the number of parameters used
to describe items [21]. Consequently, the type of linking
and the accuracy of the resulting crosswalk may depend in
part on the specific IRT model used.
The most basic form of IRT-based linking is possible
when the responses on the two instruments follow the
same Rasch model; that is, if it can be shown that they
pertain to the same unidimensional latent trait and that
all items are equally discriminating. In the Rasch model,
the observed sum score is a sufficient statistic for the la-
tent trait estimate [22]. If the Rasch model fits, linking
boils down to estimating the trait level associated with
an observed score on instrument A and then finding the
observed score on instrument B associated with that
trait level. In this approach, the statistical equating error
is merely a function of the reliability of the two instru-
ments, that is, the reliability with which trait levels can
be estimated using either of the two instruments.
If the Rasch model does not fit, a more general model
can be used such as a two-parameter IRT model that in-
cludes a discrimination parameter for differentially weight-
ing the association of items with the latent variable.
Although this extension may improve model fit, linking is
less straightforward as the observed sum score is no lon-
ger a sufficient statistic for the trait level and, conditional
on an observed sum score, estimates of trait levels vary to
some degree. In this approach, an observed score on in-
strument A is associated with an expected trait level and
from this expectation an expected observed score on in-
strument B is estimated. As such, the resulting crosswalk
contains a second source of statistical error, attributable to
the variation of the trait level given observed sum scores.
This error, in turn, is a function of the magnitude of the
discrimination indices, that is, the strength of the associ-
ation of the items with the latent variable.
The linking approach can be further generalized by as-
suming that the two instruments measure two different,
yet correlated latent variables. This situation can be
modeled by a two-dimensional IRT model, where the re-
sponses on one instrument pertain to one latent variable,
and the aggregation of the two latent variables has a
two-dimensional normal distribution. Again, the ob-
served sum score on instrument B is estimated from the
observed score on instrument A via the IRT model.
Added to the two sources of statistical error already
identified, is an error associated with the magnitude of
the correlation between the two latent variables, that is,
the strength of the association between the two assumed
latent scales.
To date, no studies have attempted to link PF-10 and
HAQ-DI scores. Moreover, although many studies have
reported high correlations between the instruments, the
degree and consequences of the multidimensionality that
would result from combining the scales are unclear.
Some previous studies have suggested that the PF-10
and HAQ-DI, or a selection of its items used in the
modified HAQ, do essentially measure the same concept
[23,24]. However, studies that examined whether items
from both scales could actually be calibrated on a com-
mon IRT metric did not unequivocally support either a
unidimensional or multidimensional latent structure
[25,26]. Moreover, these studies did not compare the
performance of different IRT models to further examine
the impact of multidimensionality.
This study presents the development and evaluation of
a crosswalk between the PF-10 and the HAQ-DI in a
large and clinically diverse sample of patients with RA
who completed both instruments. The appropriateness
of different IRT models is taken into account by com-
paring the calibrations and performance of a crosswalk
based on a one-parameter Rasch model with those of its
two-parameter and multidimensional extensions. The
accuracy of the final crosswalk is cross-validated in an
independent sample of patients with early RA participat-
ing in a treatment-to-target study.
Methods
Study populations
Two independent datasets were used for this study. The
first dataset was used for IRT calibrations and develop-
ment and comparison of the crosswalks between the PF-
10 and the HAQ-DI. Accuracy and validity of the final
crosswalk were tested in the second dataset.
Calibration sample
This dataset was derived from the Dutch Rheumatoid
Arthritis Monitoring (DREAM) registry [27]. The DREAM
registry is an observational multicenter cohort study that
monitors the course of RA patients undergoing different
treatment regimens in the Netherlands. Clinical, labo-
ratory, and patient-reported outcomes are routinely
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collected and stored. Patient-reported outcomes are gener-
ally completed online. Within the different DREAM co-
horts, 1791 unique patients simultaneously completed the
SF-36 and HAQ-DI at least once between 2003 and 2012.
For every patient, the first available simultaneous assess-
ment was selected for analysis.
Cross-validation sample
The second, independent dataset included data from pa-
tients participating in the DREAM remission induction
cohort [28]. The remission induction cohort consists of
patients with early RA participating in a treat-to-target
strategy aimed at achieving fast remission. The strategy
has been shown to be highly effective, with the largest
improvement in disease activity observed in the first
6 months of treatment [28]. Data from 532 patients who
completed the HAQ-DI and SF-36 at baseline were used
to cross-validate the accuracy of the Rasch-based cross-
walk. To study the longitudinal performance of the cross-
walk, available data of 276 patients who also completed
the HAQ and PF-10 after six months were used.
Measures
SF-36 physical functioning scale (PF-10)
The PF-10 is one of the eight scales of the SF-36 Health
Survey and consists of 10 items measuring perceived
current limitations in a variety of physical activities on a
3-point response scale from 1 (yes, limited a lot) to 3
(no, not limited at all). Where there are no missing data,
observed PF-10 scores can have 21 possible values, with
higher scores indicating more favorable levels of physical
functioning. Using traditional scoring, scores on the PF-
10 items are summed and linearly transformed to range
between 0 and 100. Additionally, the summed scores can
be standardized using norm-based scoring based on a
mean score of 50 and a standard deviation of 10 in the
1998 US general population [29]. Previous Rasch model-
ing of the PF-10 indicated that the items form a uni-
dimensional, hierarchical continuum with stable item
difficulty estimates across diverse patient groups [24,30].
Health Assessment Questionnaire disability index (HAQ-DI)
The HAQ-DI contains 20 items measuring physical dis-
abilities over the past week in eight categories of daily liv-
ing: dressing and grooming, rising, eating, walking,
hygiene, reach, grip, and activities. Each item is scored on
a 4-point rating scale from 0 (without any difficulty) to 3
(unable to do). Additionally, the HAQ-DI contains four
sections on the use of aids and devices or need for help
from another person for performing activities in any of
the eight categories. Two scoring methods can be used to
calculate total HAQ-DI scores [31]. The standard disabil-
ity index (SDI) adjusts category scores upwards for the use
of aids or devices or help from others. The alternative
disability index (ADI) does not take the use of aids and de-
vices into account. For both scoring methods, the total
disability score (HAQ-DI) is calculated by determining the
highest score in each of the eight categories and then aver-
aging the category scores. As a result, observed scores on
the HAQ-DI can take on 25 possible values between 0
and 3, with higher values indicating more disability. Re-
cent Rasch analyses have shown that the categories of the
HAQ-DI constitute a unidimensional scale [24,32].
Statistical analyses
IRT modeling
The maximum likelihood estimation procedure was uti-
lized to estimate the structural model parameters and
the latent disability levels of patients were estimated
using the expected a posteriori (EAP) method through-
out all IRT analyses. Model fit of all estimated models
was assessed using Lagrange multiplier (LM) item fit
statistics specifically targeted at polytomously scored
items [33,34]. Absolute differences (effect sizes; ES) be-
tween expected and observed item scores for high, aver-
age and low scoring individuals were computed. In
accordance with previous research, model fit was consid-
ered acceptable if all ES statistics were <0.10 [35,36]. As
the ES is weighted by the number of response categories,
this cutoff reflects differences between observed and ex-
pected score frequencies of 2.5% for the HAQ-DI and
3.33% for the PF-10, respectively. All IRT analyses were
performed with the MIRT software package [37].
Development of the crosswalk
Initial IRT analysis and cross-calibration of the PF-10
and HAQ-DI were performed in the calibration sample.
To achieve consistent response patterns, PF-10 scores
were reversed (so a lower score indicates better func-
tion) preceding analysis. Item parameters for the Rasch-
based crosswalk were obtained using the polytomous
partial credit model (PCM) [38]. First, the 10 PF-10
items and the eight HAQ-DI category scores were jointly
calibrated in the same model. After the structural model
parameters were estimated, questionnaire-specific scor-
ing runs on the HAQ-DI and PF-10 items only were per-
formed to estimate EAP scores associated with all
possible total score levels and to create scoring tables
mapping this relation. In these runs the item parameters
of the HAQ-DI and PF-10 items, respectively, were fixed
to the values obtained in the initial co-calibration. Sub-
sequently, each possible total score was linked to the
total score on the other instrument for which the abso-
lute distance between EAP scores on the latent scale was
the smallest. The total procedure was separately per-
formed for both the HAQ-SDI based category scores
and the HAQ-ADI based category scores.
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Next, the validity and appropriateness of the Rasch-
based crosswalk was evaluated by determining its pre-
cision to correctly predict HAQ-DI scores from PF-10
scores and vice versa and comparing the results to the
precision of two additional crosswalks that were developed
using the two-parameter and multidimensional extensions
of the PCM. Using the same general approach as outlined
above, we first re-estimated the model parameters using
the generalized partial credit model (GPCM). The GPCM
model is a two-parameter IRT model for polytomous data
which includes a discrimination parameter that accounts
for the different reliability of individual items with respect
to measuring the underlying latent trait. As such, the
PCM is nested within the GPCM. Finally, a between-item,
multidimensional GPCM model was estimated. Again, the
GPCM model is nested within the multidimensional
GPCM model. In this model, all items were specified to
load on their own questionnaire-specific dimension, and
the relation between the dimensions was modeled by their
correlation. Because in this model the two dimension-
specific EAP scores are estimated concurrently, no separ-
ate scoring runs needed to be performed for the HAQ-DI
and PF-10 to obtain questionnaire-specific EAP estimates
associated with all possible total scores.
Agreement between patients’ observed and predicted
scores on the PF-10 and HAQ-DI was assessed by com-
puting intraclass correlation coefficients (ICCs) with
95% confidence intervals using two-way mixed effects
models with absolute agreement for single measure-
ments (type A,1) [39]. ICCs were considered adequate
for group level comparisons when ≥0.70 [40].
Cross-validation of the results
The final step of the analyses was to apply the crosswalk in
the cross-validation sample and to evaluate the agreement
between observed and predicted HAQ-DI and PF-10
scores. Agreement between patients’ observed and cross-
walked scores on the PF-10 and HAQ-DI at baseline (n =
532) was again assessed by computing ICCs (type A,1).
Additionally, Bland-Altman plots of the difference against
the mean of predicted and observed scores were con-
structed [41,42]. As a final test of the validity of the cross-
walk, observed and predicted change scores and total
effect sizes (Cohen’s d) were calculated for patients who
completed both measures at baseline and 6-month follow-
up (n = 276). The relative efficiency of the change scores to
discriminate between responder status was analyzed using
one-way analysis of variance (ANOVA) tests [43,44]. The
28-joint Disease Activity Score (DAS28), a pooled index
that includes a tender joint count, a swollen joint count,
the erythrocyte sedimentation rate, and the patient’s global
assessment of general health, was used as the external cri-
terion for determining response to treatment [45]. Patients
were classified as good responders at 6 months when the
DAS28 score had improved at least 1.2 points and the final
score was ≤3.2 [46]. For purposes of comparing results,
relative validity (RV) coefficients with 95% bias-corrected
and accelerated bootstrap confidence intervals [44,47] for
the predicted scores in relation to the actual observed
scores were computed.
Results
Patient characteristics
The calibration and cross-validation samples were com-
parable with respect to demographic characteristics
(Table 1). However, baseline physical functioning levels
were substantially better in the cross-validation sample, as
measured with both the HAQ-DI and the PF-10. Patients
in the cross-validation sample had moderately active dis-
ease on average at baseline according to the DAS28.
Development of the Rasch-based crosswalk
Total scores on the PF-10 and HAQ-DI were strongly cor-
related (r = −0.75 for both the HAQ-SDI and HAQ-ADI).
Both the Rasch-based co-calibration of the HAQ-SDI and
PF-10 items and the co-calibration of HAQ-ADI and
PF-10 items resulted in a model that adequately fitted the
data according to the LM tests, with all accompanying
ESs <0.10 (Additional file 1: Table S1 and S2).
Figure 1 presents the test information functions which
describe the local reliability of the PF-10 and HAQ-SDI.
Both scales measured an approximately equally wide
range of physical functioning with high precision. Over-
all, the PF-10 was slightly more precise at better levels of
physical functioning (i.e., lower theta values), whereas
the HAQ-SDI tended to provide more information at
worse levels of functioning.
Table 2 presents the resulting Rasch-based crosswalks
between the PF-10 and HAQ-DI. Separate cross-walks
Table 1 Patient characteristics
Calibration Cross-validation
sample sample
(n = 1791) (n = 532)
Sex, % female 69.2 63.0
Age in years, mean (SD) 56.54 (13.31) 56.48 (14.26)
HAQ-SDI (0–3), mean (SD)* 1.08 (0.71) 0.65 (0.65)
PF-10 (0–100), mean (SD) 53.89 (26.35) 67.39 (25.71)
DAS28, mean (SD)* - 4.28 (1.51)
VAS Pain (0–100), mean (SD)* - 43.38 (26.23)
VAS General Health (0–100), mean (SD)* - 44.49 (26.48)
HAQ-SDI = Health Assessment Questionnaire standard disability index; PF-10 =
SF-36 physical functioning scale; DAS28 = 28-joint Disease Activity Score; VAS
Pain = visual analog scale for patient’s pain in the past week; VAS General
Health = visual analog scale for patient’s general health in the past week.
* Higher values indicate worse health states.
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are presented for the standard and alternative scoring
rule of the HAQ-DI. As would be expected, predicted
HAQ-ADI scores were generally lower than predicted
HAQ-SDI scores, for a given level of the PF-10. This ef-
fect was strongest in the range of HAQ-DI scores from
1 to 2, where for the same observed PF-10 total scores,
the estimated HAQ-SDI scores were consistently 0.25
points (i.e. two score levels) higher than the HAQ-ADI
scores. Observed HAQ-ADI and HAQ-SDI scores ≥2.75
were linked to locations on the EAP theta scale that
were below the lowest possible score for the PF-10 scale.
Conversely, observed PF-10 scores of 95 and 100 were
linked to EAP scores that reflect levels of function that
are not represented in the HAQ-DI. They were therefore
linked to the value zero in the crosswalks.
Figure 1 Test information function curve (partial credit model)
for the HAQ-SDI and PF-10 in relation to theta. The test
information function is the sum of all separate item information
functions. Higher positive theta scores indicate worse
physical functioning.
Table 2 Rasch-based crosswalk for transforming PF-10 scores into HAQ-DI scores and vice versa
HAQ standard scoring (with aids and devices) HAQ alternative scoring (without aids and devices)
Observed Predicted Observed Predicted Observed Predicted Observed Predicted
HAQ-SDI PF-10 PF-10 HAQ-SDI HAQ-ADI PF-10 PF-10 HAQ-ADI
score score* score* score score score* score* score
0.000 95 (54.9) 100 (57.0) 0.000 0.000 95 (54.9) 100 (57.0) 0.000
0.125 90 (52.8) 95 (54.9) 0.000 0.125 85 (50.7) 95 (54.9) 0.000
0.250 85 (50.7) 90 (52.8) 0.125 0.250 80 (48.6) 90 (52.8) 0.125
0.375 75 (46.5) 85 (50.7) 0.250 0.375 75 (46.5) 85 (50.7) 0.125
0.500 75 (46.5) 80 (48.6) 0.250 0.500 70 (44.4) 80 (48.6) 0.250
0.625 70 (44.4) 75 (46.5) 0.375 0.625 65 (42.3) 75 (46.5) 0.375
0.750 65 (42.3) 70 (44.4) 0.625 0.750 55 (38.1) 70 (44.4) 0.500
0.875 60 (40.2) 65 (42.3) 0.750 0.875 50 (36.0) 65 (42.3) 0.625
1.000 55 (38.1) 60 (40.2) 0.875 1.000 45 (33.9) 60 (40.2) 0.625
1.125 50 (36.0) 55 (38.1) 1.000 1.125 45 (33.9) 55 (38.1) 0.750
1.250 45 (33.9) 50 (36.0) 1.125 1.250 40 (31.8) 50 (36.0) 1.000
1.375 45 (33.9) 45 (33.9) 1.375 1.375 35 (29.7) 45 (33.9) 1.125
1.500 40 (31.8) 40 (31.8) 1.500 1.500 30 (27.6) 40 (31.8) 1.250
1.625 35 (29.7) 35 (29.7) 1.625 1.625 25 (25.5) 35 (29.7) 1.375
1.750 30 (27.6) 30 (27.6) 1.750 1.750 25 (25.5) 30 (27.6) 1.500
1.875 25 (25.5) 25 (25.5) 1.875 1.875 25 (25.5) 25 (25.5) 1.750
2.000 20 (23.4) 20 (23.4) 2.125 2.000 20 (23.4) 20 (23.4) 2.000
2.125 20 (23.4) 15 (21.3) 2.250 2.125 15 (21.3) 15 (21.3) 2.125
2.250 15 (21.3) 10 (19.2) 2.375 2.250 10 (19.2) 10 (19.2) 2.250
2.375 10 (19.2) 5 (17.0) 2.625 2.375 10 (19.2) 5 (17.0) 2.625
2.500 5 (17.0) 0 (14.9) 2.750 2.500 5 (17.0) 0 (14.9) 2.750
2.625 5 (17.0) 2.625 5 (17.0)
2.750 0 (14.9) 2.750 0 (14.9)
2.875 0 (14.9) 2.875 0 (14.9)
3.000 0 (14.9) 3.000 0 (14.9)
*Scores are original 0–100 transformed scale scores, 1998 US norm-based T-scores are presented between brackets.
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Comparative performance of the Rasch-based crosswalk
Model fit of the co-calibrations based on the two-
parameter GPCM and the multi-dimensional IRT model
improved marginally as compared with the Rasch model
(Additional file 1: Table S3–S6). For both the GPCM
and the multi-dimensional model, ESs were also <0.10
and generally slightly smaller than those observed in the
Rasch model. The correlation between the latent dimen-
sions in the multidimensional models was 0.73. The
crosswalks based on the GPCM and multi-dimensional
IRT model were almost identical to the Rasch-based
crosswalk. Correlations between predicted scores based
on the different crosswalks were very high (r’s >0.988).
Moreover, the crosswalks based on the two-parameter
and multidimensional models did not perform substan-
tially better in terms of agreement between observed
and predicted total scores on the PF-10 and HAQ-DI
(Table 3). Considering that the Rasch-based calibration
fitted the data well according to pre-specified criteria
and that the agreement between observed and predicted
scale scores did not improve much in the more general
models, it was concluded that the Rasch-based crosswalk
was adequate for converting total scale scores.
Cross-validation of the results
The agreement between observed scores and scores pre-
dicted from the Rasch-based crosswalk was high in the
cross-validation sample. The ICCs (95% CI) between
predicted and actual scores were 0.78 (0.74 to 0.81) for
the HAQ-SDI, 0.77 (0.72 to 0.80) for the HAQ-ADI and
0.79 (0.75 to 0.82) for the PF-10, indicating adequate
agreement for group-level comparisons. Additionally,
group mean differences on both scales were small in
magnitude (Table 4). Intra-individual differences were
similarly distributed above and below the mean and not
related to the magnitude of the measurement (Figure 2).
However, the limits of agreement were wide for both
scales and showed substantial discrepancies in agree-
ment within individual patients.
With respect to the observed 6-month change scores
in the total cross-validation sample (Table 5), standard-
ized improvements were largest for the HAQ-DI (ES =
0.55), closely followed by the HAQ-SDI (ES = 0.49) and
the PF-10 (ES = 0.40). In terms of differentiating between
levels of longitudinal treatment response, the HAQ-ADI
was slightly more efficient than the HAQ-SDI and PF-
10. Relative validity coefficients of the predicted scores
were close to, and not significantly different from, those
of the actual observed scores for all three scales.
Discussion
This study used IRT methods to analyze and link two
widely used scales for measuring physical functioning,
the PF-10 and the HAQ-DI. Results showed that it was
possible to develop a straightforward Rasch-based cross-
walk between both scales that can be used to estimate
scores on one scale from scores on the other in patients
with RA. The Rasch-based crosswalk performed simi-
larly to crosswalks based on its two-parameter and
multidimensional extensions. The application of the
crosswalk in an independent sample of patients with
early RA indicated that the crosswalk can be validly used
for group-level analyses in RA populations.
Test linking or test equating has long been the focus of
research in educational and psychological settings [12,48].
More recently, the desire for standardization has also
found its way to health outcomes measurement. As in edu-
cational testing, linking of existing health outcome ins-
truments could enhance meaningful comparison and
Table 3 Agreement (ICC, 95% CI) between observed and
predicted total scale scores using crosswalks based on
the different IRT models in the calibration sample
(n = 1791)
Rasch Two-parameter Multi-
dimensional
model model model
HAQ-SDI 0.739 (0.717 to
0.760)
0.741 (0.719 to
0.762)
0.739 (0.717 to
0.760)
HAQ-ADI 0.737 (0.714 to
0.758)
0.737 (0.715 to
0.758)
0.735 (0.712 to
0.756)
PF-10 (predicted
from HAQ-SDI)
0.746 (0.724 to
0.767)
0.745 (0.722 to
0.765)
0.742 (0.720 to
0.763)
PF-10 (predicted
from HAQ-ADI)
0.748 (0.726 to
0.768)
0.750 (0.728 to
0.770)
0.749 (0.727 to
0.769)
ICC = intraclass correlation coefficient; HAQ-SDI = Health Assessment Questionnaire
standard disability index; HAQ-ADI = Health Assessment Questionnaire alternative
disability index; PF-10 = SF-36 physical functioning scale.
Table 4 Agreement between observed and predicted
scores on the HAQ-DI and PF-10 in the cross-validation
sample (n = 532)
ICC
(95%
CI)
Mean
(SD)
Mean
(SD)
Mean
(SD)
LOA
observed
scores
predicted
scores
difference
HAQ-SDI 0.78
(0.74 to
0.81)
0.65 (0.64) 0.72 (0.71) −0.07
(0.44)
−0.93
to 0.80
HAQ-ADI 0.77
(0.72 to
0.80)
0.53 (0.57) 0.63 (0.65) −0.10
(0.40)
−0.88
to 0.68
PF-10
(predicted
from HAQ-SDI)
0.79
(0.75 to
0.82)
67.39
(25.71)
69.60
(23.26)
−2.21
(15.80)
−33.18
to
28.76
PF-10
(predicted
from HAQ-ADI)
0.79
(0.76 to
0.82)
67.39
(25.71)
69.62
(23.01)
−2.23
(15.64)
−32.88
to
28.42
HAQ-DI = Health Assessment Questionnaire Disability Index; PF-10 = SF-36
physical functioning scale; ICC = intraclass correlation coefficient; LOA = Bland-
Altman limits of agreement (mean difference ± 1.96×SD of the difference).
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interpretation of results across studies and populations.
With the rise of IRT in health outcomes assessment, new
techniques have become available to achieve this objective.
This is reflected in an increasing number of studies that
have linked different patient-reported measures using IRT-
based methods, including several measures of physical
functioning [15,17,19,49-55]. These crosswalks allow re-
searchers to compare their results with studies and popula-
tions where another instrument was used and may
improve the common understanding of the specific under-
lying construct. Moreover, they may be particularly useful
for compilation of findings in meta-analytic studies or lon-
gitudinal studies focusing on measuring effects or changes
[56]. A such, crosswalks are an important step in achieving
better interpretation and comparability of patient-reported
outcomes measures across different studies [57]. A next
possible step in the standardization and promotion of a
common measurement system of patient-reported out-
comes, is the development of large IRT-calibrated item
banks such as those developed by the Patient-Reported
Outcomes Measurement Information System (PROMIS)
initiative [58]. These item banks can be used to build flex-
ible short forms and computer adaptive tests for different
populations or clinical conditions, while scores on these
measures remain directly comparable. Recent studies have
already shown the promise of this approach in RA [59].
The current study used an elaborate approach for cross-
calibrating the HAQ-DI with the PF-10 and developing
and evaluating the crosswalk, especially in its choice for
comparing different IRT models. IRT linking studies usu-
ally do not explain or justify their use of a specific IRT
model, such as the Rasch model or more general models.
When using IRTanalysis, however, the differences in model
assumptions should be taken into account and the final
model choice should be motivated by considering aspects
such as the unidimensionality and the discrimination
equality of the items [60]. Moreover, it should be shown to
what degree the used model holds. In the case of using IRT
for linking total scale scores, the specific model used may
have consequences for the robustness and accuracy of the
resulting crosswalk. This article presents a straightforward
and practical IRT-based approach of linking total scale
scores that includes comparing the fit and performance of
different nested IRT models. This approach can be used
for future studies aimed at linking different instruments
intended to measure the same construct. An important
feature of the approach is that it can be used for cali-
brating scales with polytomous items, which is the case
with most patient-reported outcomes. Contrary to the
Rasch model, tests of model fit for more complex
models for polytomous items which are based on test
statistics with known asymptotic distributions are rare.
Figure 2 Bland-Altman plots for agreement between observed and predicted HAQ-SDI (top left), HAQ-ADI (top right) and PF-10 scores
(bottom left: predicted from HAQ-SDI, bottom right: predicted from HAQ-ADI). The y-axes represent the difference between observed and
predicted scores. The x-axes represent the mean of observed and predicted scores. The horizontal solid lines represent the mean difference
between both scores. The dashed lines represent the 95% limits of agreement.
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Therefore, the presented approach uses the LM test
throughout all fit analyses [34].
Additionally, most IRT linking studies to date have not
tested the performance of the crosswalks in clinically dif-
ferent, independent samples. To our knowledge, this
study is the first to cross-validate a crosswalk of physical
functioning scales in a clinical setting. One recent study
did validate a crosswalk for fatigue using data from a
subsequent time point, but acknowledged that using an
independent sample would have been preferable [56].
With the objective in mind of creating a robust cross-
walk in this study, its development was performed in a
large and diverse sample of RA patients with a wide
range of physical functioning levels. Subsequently, the
performance of the crosswalk was examined in a specific
sample of patients with early disease.
The results of the IRT calibrations suggested that the
PF-10 and the HAQ-DI essentially measure the same uni-
dimensional construct and could be adequately fitted to
the same Rasch model. The finding that the simple Rasch
model performed similarly to more general models in cali-
brating both scales may have several theoretical and
practical advantages [61-63]. An advantage in the case of
total score linking is that each observed total instrument
score is associated with only one latent trait (theta) score,
making the resulting crosswalk more straightforward and
robust against statistical error.
The evaluation of the measurement precision of the
PF-10 and HAQ-DI under the Rasch model showed that
the HAQ-DI and the PF-10 both measured a wide range
of physical functioning in patients with RA. However,
the HAQ-DI provided its optimal measurement preci-
sion at worse levels of physical function, whereas the
PF-10 had better precision at somewhat better levels on
the physical function continuum. This corresponds with
previously reported ceiling effects of the HAQ-DI in less
disabled populations [24,64-66] and floor effects of the
PF-10 in more disabled populations [67-70]. These ef-
fects were also apparent in the final crosswalk, where
the HAQ-DI was better able to distinguish different
scores at the lower end of the physical functioning
spectrum and the PF-10 could better distinguish scores
at the upper end. This supports previous findings that
combining items from the HAQ-DI and PF-10 can re-
duce floor and ceiling effects and results in a scale with
increased measurement precision and sensitivity to
change across a wider range of physical functioning [25].
In the current study, separate crosswalks were devel-
oped for so-called standard (SDI) and alternative disability
index (ADI) scoring of the HAQ-DI [5]. In the standard
scoring method, the score on a category of daily living is
corrected upwards when a respondent indicates the use of
help from others or a device for performing one of the
items in this category. Consequently, SDI scores are gener-
ally higher than ADI scores. Although the average differ-
ence between both scoring methods has been reported to
be very small in general populations or populations with
mild disability [71], SDI scores have been shown to be up
to 0.15 to 0.26 points higher than ADI scores in samples
with increasing disability levels [65,72-74]. In the current
study, this resulted in higher predicted scores for the SDI
than for the ADI, especially for patients with worse levels
of functioning. Therefore, care must be taken in using the
correct crosswalk when converting PF-10 and HAQ-DI
scores. Unfortunately, published studies do not always
clearly specify which method was used to compute the
HAQ-DI scores [75,76]. If necessary and possible, re-
searchers should therefore re-analyze the original data to
compute the correct HAQ-DI scores.
Additionally, we presented the cross-walk for both the
original and the norm-based scoring method of the PF-
10. The original 0–100 scoring has been most frequently
used in the literature to date. Since the introduction of
version 2 of the SF-36, however, all eight scales can also
be linearly transformed to T-scores based on normative
data from the US general population [29]. This norm-
Table 5 Baseline to 6-month effect sizes and mean (SD)
changes in physical functioning scores across levels of
DAS28 treatment response in the cross-validation sample
(n = 276)
Total
ES
Non- or
moderate
responders
Good
responders
F RV 95%
CI
(n = 142) (n = 134)
HAQ-ADI
Observed 0.55 −0.20 (0.52) −0.62 (0.58) 38.59 1.00
Predicted 0.37 −0.14 (0.54) −0.50 (0.55) 30.12 0.78 0.35
to
1.69
HAQ-SDI
Observed 0.49 −0.17 (0.44) −0.49 (0.49) 30.63 1.00
Predicted 0.38 −0.14 (0.53) −0.51 (0.55) 32.38 1.06 0.44
to
2.25
PF-10
Observed 0.40 5.53 (20.15) 19.63
(20.74)
32.80 1.00
Predicted
from
HAQ-ADI
0.55 7.85 (19.99) 24.33
(21.98)
42.52 1.18 0.63
to
3.35
Predicted
from
HAQ-SDI
0.48 6.23 (15.34) 16.98
(16.68)
31.09 0.86 0.43
to
2.36
PF-10 = SF-36 physical functioning scale; HAQ-SDI = Health Assessment
Questionnaire standard disability index; HAQ-ADI = Health Assessment
Questionnaire alternative disability index; ES = Cohen’s d effect size;
F = F-statistic from one-way ANOVA; RV = Relative validity (ratio of F-statistics
compared with observed score); 95% CI = 95% bootstrap bias-corrected and
accelerated confidence interval.
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based scoring method has become increasingly popular
as it allows for easier interpretation of differences across
scales and populations.
The two RA samples used to develop and evaluate the
crosswalk in this study correspond with the two major pop-
ulations of interest in current clinical studies in RA. The
sample used to cross-calibrate the PF-10 and HAQ-DI rep-
resents the general and clinically diverse RA population
seen in the everyday clinical practice and the distribution
of age, sex, and functional disability scores in this sample
corresponds closely with the characteristics reported in
other large observational studies [77-79]. The cross-
validation was performed in a sample of RA patients with
a maximum symptom duration of one year. This popula-
tion is gaining increasing research interest, mainly due to
the development of effective biological treatments and the
implementation of new treatment guidelines [80,81]. The
finding that the crosswalk also performed well in this very
specific sample, provides further support for its wide ap-
plicability in RA research.
It should be noted, however, that RA is characterized
by very specific disease mechanisms and physical mani-
festations, such as a high frequency of dexterity prob-
lems. Consequently, the IRT item parameters of the
HAQ-DI and PF-10 may vary between conditions and
populations as was previously shown for the HAQ-DI
across different rheumatic diseases [35]. Therefore, fu-
ture studies should cross-validate the crosswalk in both
general and other disease-specific populations.
Further, the crosswalk is not suitable for use at the indi-
vidual patient level. Although ICCs between observed and
predicted scores were adequate for group-level analyses,
they were not sufficiently high to warrant individual level
analyses. This was confirmed by the Bland-Altman ana-
lyses, which showed that observed and predicted scores
were characterized by high intra-individual variation.
Therefore, cross-walked scores are not equivalent at an in-
dividual level and cannot be used interchangeably.
Conclusions
In sum, the crosswalk developed in this study enables
the conversion of PF-10 scores into HAQ-DI scores and
vice versa in patients with RA. Using the crosswalk will
allow for group-level comparisons of data from studies
that used either of the scales and can facilitate more
meaningful interpretation and comparison of results.
Future studies should examine the robustness of the
crosswalk in other populations.
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